Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
3,830
Views
50
CrossRef citations to date
0
Altmetric
Research Article

In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates

Alessandro GiulianiDepartment of Veterinary Medical Science, Alma Mater Studiorum – University of Bologna, Ozzano, Italy;
,
Anna Giulia BalducciDepartment of Food and Drug, University of Parma, Parma, Italy; ;Interdepartmental Center for Health Products – Biopharmanet TEC, University of Parma, Parma, Italy;
,
Elisa ZironiDepartment of Veterinary Medical Science, Alma Mater Studiorum – University of Bologna, Ozzano, Italy;
,
Gaia ColomboDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy;
,
Fabrizio BortolottiDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy;
,
Luca LorenziniIRET Foundation, Ozzano, (BO), Italy;
,
Viola GalligioniDepartment of Veterinary Medical Science, Alma Mater Studiorum – University of Bologna, Ozzano, Italy;
,
Giampiero PagliucaDepartment of Veterinary Medical Science, Alma Mater Studiorum – University of Bologna, Ozzano, Italy;
,
Alessandra ScagliariniDepartment of Veterinary Medical Science, Alma Mater Studiorum – University of Bologna, Ozzano, Italy;
,
Laura CalzàIRET Foundation, Ozzano, (BO), Italy; ;Department of Pharmacy and Biotechnology, Ozzano, Italy
&
Fabio SonvicoDepartment of Food and Drug, University of Parma, Parma, Italy; ;Interdepartmental Center for Health Products – Biopharmanet TEC, University of Parma, Parma, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7372-1456
ORCID Icon show all
Pages 376-387 | Received 25 Oct 2017, Accepted 11 Jan 2018, Published online: 30 Jan 2018

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong & Jingqing Zhang. (2021) Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. International Journal of Nanomedicine 16, pages 4959-4984.
Read now
Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone & Rosario Pignatello. (2021) Nanotechnologies for intranasal drug delivery: an update of literature. Pharmaceutical Development and Technology 26:8, pages 824-845.
Read now
Chandrakant Kokare, Dhanashri Koli, Dnyandev Gadhave, Chandrashekhar Mote & Gajendra Khandekar. (2020) Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation. Pharmaceutical Development and Technology 25:1, pages 28-39.
Read now
Laura Tiozzo Fasiolo, Michele Dario Manniello, Fabrizio Bortolotti, Francesca Buttini, Alessandra Rossi, Fabio Sonvico, Paolo Colombo, Georgia Valsami, Gaia Colombo & Paola Russo. (2019) Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease. Journal of Drug Targeting 27:9, pages 984-994.
Read now
Shweta Gupta, Rajesh Kesarla & Abdelwahab Omri. (2019) Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment. Expert Opinion on Drug Delivery 16:3, pages 287-300.
Read now

Articles from other publishers (45)

Alberto Baldelli, Chun Wong, Hale Oguzlu, Hanieh Mahvizani, Hui Xin Ong, Athenea Pascual Rodriguez, Gurpreet Singhera, Andrew Thamboo, Anika Singh, Daniela Traini & Anubhav Pratap-Singh. (2023) Impact of amino acids on the properties of nasal dry powders. Journal of Drug Delivery Science and Technology, pages 104848.
Crossref
Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang & Xin-Ying Ji. (2023) Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration. iScience 26:8, pages 107321.
Crossref
Patrícia Henriques, Joana Bicker, Soraia Silva, Slavomíra Doktorovová & Ana Fortuna. (2023) Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability. International Journal of Pharmaceutics 643, pages 123252.
Crossref
Chun Yuen Jerry Wong, Alberto Baldelli, Hanieh Gholizadeh, Hale Oguzlu, Yigong Guo, Hui Xin Ong, Athenea Pascual Rodriguez, Gurpreet Singhera, Andrew Thamboo, Anika Singh, Anubhav Pratap-Singh & Daniela Traini. (2023) Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta. European Journal of Pharmaceutics and Biopharmaceutics 189, pages 202-211.
Crossref
Ghassan Mudher Hashim, Ghaidaa S. Hameed & Dalya Basil Hanna. (2023) The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:3, pages 231-249.
Crossref
Alberto Baldelli, Leeni Koivisto, Hale Oguzlu, Yigong Guo, Lari Häkkinen, Anubhav Pratap-Singh & Hannu Larjava. (2023) Spray-dried microparticles of encapsulated gefitinib for slow-release localized treatment of periodontal disease. International Journal of Pharmaceutics 642, pages 123137.
Crossref
Bakhrushina E.O., Ivkina A.S. & Tabanskaya T.V.. (2023) EVALUATION OF BIOPHARMACEUTICAL PARAMETERS OF A NEW INTRANASAL ANTIVIRAL DRUG BASED ON AN IN SITU SYSTEM. "Medical & pharmaceutical journal "Pulse", pages 6-11.
Crossref
Judy Gopal, Manikandan Muthu, Suraj Shiv Charan Pushparaj & Iyyakkannu Sivanesan. (2023) Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?. Antibiotics 12:4, pages 665.
Crossref
Anja Haasbroek‐Pheiffer, Suzanne Van Niekerk, Frank Van der Kooy, Theunis Cloete, Jan Steenekamp & Josias Hamman. (2023) In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery . Biopharmaceutics & Drug Disposition 44:1, pages 94-112.
Crossref
E. O. Bakhrushina, I. B. Mikhel, V. S. Pyzhov, N. B. Demina, I. I. KrasnyukJrJr & I. I. Krasnyuk. (2023) Development of In Situ Intranasal System Based on Chitosan Formate. Bulletin of Experimental Biology and Medicine 174:3, pages 337-340.
Crossref
Tayo Alex Adekiya, Mumuni Sumaila, Raphael Taiwo Aruleba & Yahya E. Choonara. 2023. Viral Drug Delivery Systems. Viral Drug Delivery Systems 91 117 .
A.C. Correia, A.R. Monteiro, R. Silva, J.N. Moreira, J.M. Sousa Lobo & A.C. Silva. (2022) Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders. Advanced Drug Delivery Reviews 189, pages 114485.
Crossref
Vivek P. Chavda, Gargi Jogi, Nirav Shah, Mansi N. Athalye, Nirav Bamaniya, Lalitkumar K Vora & Ana Cláudia Paiva-Santos. (2022) Advanced particulate carrier-mediated technologies for nasal drug delivery. Journal of Drug Delivery Science and Technology 74, pages 103569.
Crossref
Mirna Perkušić, Laura Nižić Nodilo, Ivo Ugrina, Drago Špoljarić, Cvijeta Jakobušić Brala, Ivan Pepić, Jasmina Lovrić, Gordana Matijašić, Matija Gretić, Dijana Zadravec, Livije Kalogjera & Anita Hafner. (2022) Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery. International Journal of Pharmaceutics 624, pages 122038.
Crossref
Patrícia Henriques, Ana Fortuna & Slavomíra Doktorovová. (2022) Spray dried powders for nasal delivery: Process and formulation considerations. European Journal of Pharmaceutics and Biopharmaceutics 176, pages 1-20.
Crossref
Sheldon JordanMargaret ZielinskiMarcin KortylewskiTaylor KuhnAlexander Bystritsky. (2022) Noninvasive Delivery of Biologicals to the Brain. FOCUS 20:1, pages 64-70.
Crossref
Honey Goel, Vinni Kalra, Sant Kumar Verma, Sunil Kumar Dubey & Ashok Kumar Tiwary. (2022) Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Journal of Controlled Release 341, pages 782-811.
Crossref
Pallavi Kiran, Sujit Kumar Debnath, Suditi Neekhra, Vaishali Pawar, Amreen Khan, Faith Dias, Shubham Pallod & Rohit Srivastava. (2021) Designing nanoformulation for the nose‐to‐brain delivery in Parkinson's disease: Advancements and barrier. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Haihong Zhou, Furong Sun, Mingqian Ou, Yu Zhang, Meijun Lin, Liqin Song, Yangsheng Yu, Haojie Liao, Weihao Fan, Huaijie Xing, Minhua Li, Kui Zhao, Xiaolian Wu, Yuanhong Sun, Chunmei Liang, Yujie Cai & Lili Cui. (2021) Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury. Molecular Therapy 29:12, pages 3465-3483.
Crossref
Paraskevi Papakyriakopoulou, Konstantina Manta, Christina Kostantini, Stefanos Kikionis, Sabrina Banella, Efstathia Ioannou, Eirini Christodoulou, Dimitrios M. Rekkas, Paraskevas Dallas, Maria Vertzoni, Georgia Valsami & Gaia Colombo. (2021) Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation. International Journal of Pharmaceutics 607, pages 121016.
Crossref
Flavia Laffleur & Bettina Bauer. (2021) Progress in nasal drug delivery systems. International Journal of Pharmaceutics 607, pages 120994.
Crossref
Hetal P. Patel, Priyanshi A. Gandhi, Priyanka S. Chaudhari, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Furqan A. Maulvi & Bhavin A. Vyas. (2021) Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 64, pages 102533.
Crossref
Laura Tiozzo Fasiolo, Michele Dario Manniello, Sabrina Banella, Laura Napoli, Fabrizio Bortolotti, Eride Quarta, Paolo Colombo, Evangelos Balafas, Nikolaos Kostomitsopoulos, Dimitrios M. Rekkas, Georgia Valsami, Paraskevi Papakyriakopoulou, Gaia Colombo & Paola Russo. (2021) Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation. International Journal of Pharmaceutics 605, pages 120827.
Crossref
Laura Deruyver, Clément Rigaut, Pierre Lambert, Benoît Haut & Jonathan Goole. (2021) The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Advanced Drug Delivery Reviews 175, pages 113826.
Crossref
Giovanna Rassu, Milena Sorrenti, Laura Catenacci, Barbara Pavan, Luca Ferraro, Elisabetta Gavini, Maria Cristina Bonferoni, Paolo Giunchedi & Alessandro Dalpiaz. (2021) Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?. Pharmaceutics 13:8, pages 1180.
Crossref
Dipy M. Vasa, Zainab Bakri, Maureen D. Donovan, Lauren A. O’Donnell & Peter L. D. Wildfong. (2021) Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption. Pharmaceutics 13:8, pages 1126.
Crossref
Giuseppe Alastra, Luigi Aloe, Vito Antonio Baldassarro, Laura Calzà, Maura Cescatti, Jason Thomas Duskey, Maria Letizia Focarete, Daria Giacomini, Luciana Giardino, Valentina Giraldi, Luca Lorenzini, Marzia Moretti, Irene Parmeggiani, Michele Sannia & Giovanni Tosi. (2021) Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?. Frontiers in Neuroscience 15.
Crossref
Aida Maaz, Ian S. Blagbrough & Paul A. De Bank. (2021) In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery. Pharmaceutics 13:7, pages 1079.
Crossref
Luminita Georgeta Confederat, Cristina Gabriela Tuchilus, Maria Dragan, Mousa Sha’at & Oana Maria Dragostin. (2021) Preparation and Antimicrobial Activity of Chitosan and Its Derivatives: A Concise Review. Molecules 26:12, pages 3694.
Crossref
Federica Rinaldi, Linda Maurizi, Jacopo Forte, Massimiliano Marazzato, Patrizia Hanieh, Antonietta Conte, Maria Ammendolia, Carlotta Marianecci, Maria Carafa & Catia Longhi. (2021) Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells. Nanomaterials 11:6, pages 1569.
Crossref
Mitra Alami-Milani, Sara Salatin, Farzaneh Sharifi Rayeni & Mitra Jelvehgari. (2021) Preparation and in vitro evaluation of thermosensitive and mucoadhesive hydrogels for intranasal delivery of phenobarbital sodium . Therapeutic Delivery 12:6, pages 461-475.
Crossref
Sriram Chari, Karthik Sridhar, Ross Walenga & Clement Kleinstreuer. (2021) Computational analysis of a 3D mucociliary clearance model predicting nasal drug uptake. Journal of Aerosol Science 155, pages 105757.
Crossref
Laura Nižić Nodilo, Ivo Ugrina, Drago Špoljarić, Daniela Amidžić Klarić, Cvijeta Jakobušić Brala, Mirna Perkušić, Ivan Pepić, Jasmina Lovrić, Vesna Saršon, Maša Safundžić Kučuk, Dijana Zadravec, Livije Kalogjera & Anita Hafner. (2021) A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics 13:6, pages 795.
Crossref
Federica Rinaldi, Alessandra Oliva, Manuela Sabatino, Anna Imbriano, Patrizia N. Hanieh, Stefania Garzoli, Claudio M. Mastroianni, Massimiliano De Angelis, Maria Claudia Miele, Marcela Arnaut, Federica Di Timoteo, Carlotta Marianecci, Rino Ragno & Maria Carafa. (2020) Antimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery. Pharmaceutics 12:7, pages 678.
Crossref
Chitra Mohinder Singh Singal, Paritosh Jaiswal & Pankaj Seth. (2020) SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis. ACS Chemical Neuroscience 11:13, pages 1887-1899.
Crossref
Shiv Bahadur, Nidhi Sachan, Ranjit K. Harwansh & Rohitas Deshmukh. (2020) Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery. Current Pharmaceutical Design 26:12, pages 1331-1344.
Crossref
Doddy Denise Ojeda-Hernández, Alejandro A. Canales-Aguirre, Jorge Matias-Guiu, Ulises Gomez-Pinedo & Juan C. Mateos-Díaz. (2020) Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Branka Petković, Srđan Kesić & Vesna Pešić. (2020) Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder. Current Pharmaceutical Design 26:4, pages 466-484.
Crossref
Laura Nižić, Joanna Potaś, Katarzyna Winnicka, Marta Szekalska, Iva Erak, Matija Gretić, Mario Jug & Anita Hafner. (2020) Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres. European Journal of Pharmaceutical Sciences 141, pages 105115.
Crossref
Sravanthi Reddy Pailla, Sreekanth Talluri, Nagarjun Rangaraj, Ramdas Ramavath, Veerabhadra Swamy Challa, Nandkumar Doijad & Sunitha Sampathi. (2019) Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats. DARU Journal of Pharmaceutical Sciences 27:2, pages 541-556.
Crossref
Dnyandev Gadhave, Bapi Gorain, Amol Tagalpallewar & Chandrakant Kokare. (2019) Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma. Journal of Drug Delivery Science and Technology 51, pages 276-289.
Crossref
Vieri Piazzini, Elisa Landucci, Mario D'Ambrosio, Laura Tiozzo Fasiolo, Lorenzo Cinci, Gaia Colombo, Domenico E. Pellegrini-Giampietro, Anna Rita Bilia, Cristina Luceri & Maria Camilla Bergonzi. (2019) Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery. International Journal of Biological Macromolecules 129, pages 267-280.
Crossref
Prina Mehta, Ali A. Al-Kinani, Muhammad Sohail Arshad, Neenu Singh, Susanna M. van der Merwe, Ming-Wei Chang, Raid G. Alany & Zeeshan Ahmad. (2019) Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses. Journal of Pharmaceutical Sciences 108:4, pages 1540-1551.
Crossref
Laurent Salade, Nathalie Wauthoz, Jonathan Goole & Karim Amighi. (2019) How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. International Journal of Pharmaceutics 561, pages 47-65.
Crossref
Alessandro Dalpiaz & Barbara Pavan. (2018) Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?. Pharmaceutics 10:2, pages 39.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.